The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi‐institutional retrospective analysis in Japan

• Published in: Head & neck Vol. 44; no. 6; pp. 1430 - 1441
• Main Authors: Kusafuka, Kimihide, Sato, Yoko, Nakatani, Eiji, Baba, Satoshi, Maeda, Matsuyoshi, Yamanegi, Koji, Ueda, Kaori, Inagaki, Hiroshi, Otsuki, Yoshiro, Kuroda, Naoto, Suzuki, Kensuke, Iwai, Hiroshi, Imamura, Yoshiaki, Itakura, Junya, Yamanaka, Shoji, Takahashi, Hideaki, Ito, Ichiro, Akashi, Takumi, Daa, Tsutomu, Hamada, Mei, Yasuda, Masanori, Kawata, Ryo, Yamamoto, Hidetaka, Tachibana, Yuri, Fukuoka, Junya, Muramatsu, Aya, Arai, Kazumori, Suzuki, Makoto
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.06.2022; Wiley Subscription Services, Inc
• Subjects: Adenoma; Adenoma, Pleomorphic - pathology; Aged; Cancer; Carcinoma, Ductal - surgery; competing‐risk model; Female; Humans; Japan; Japanese patient; Lymph nodes; Lymphatic system; Male; Malignancy; Metastases; Metastasis; Neoplasm Recurrence, Local - epidemiology; Neoplasm Recurrence, Local - pathology; Original; outcomes; Parotid gland; Retrospective Studies; salivary duct carcinoma; Salivary Ducts - pathology; Salivary Ducts - surgery; Salivary gland; Salivary Gland Neoplasms - pathology; Salivary Gland Neoplasms - therapy; Tumors; Japan; competing-risk model; outcomes; salivary duct carcinoma; Japanese patient
• ISSN: 1043-3074; 1097-0347
• DOI: 10.1002/hed.27034

Background Salivary duct carcinoma (SDC) is a high‐grade salivary malignancy that frequently occurs as the carcinomatous component of carcinoma ex pleomorphic adenoma. We herein examined the clinical factors affecting outcomes in a large cohort of SDC. Methods We selected 304 SDC cases and investigated clinical characteristics and the factors affecting outcomes. Results The median age of the cases examined was 68 years, the most common primary site was the parotid gland (238 cases), and there was a male predominance (M/F = 5:1). Outcomes were significantly worse when the primary tumor site was the minor salivary glands (SG) than when it was the major SG. Outcomes were also significantly worse in pN(+) cases (161 cases) than in pN0 cases, particularly those with a metastatic lymph node number ≥11. The cumulative incidence of relapse and distant metastases was significantly higher in stage IV cases than in stage 0–III cases. Conclusions The absolute number of lymph node metastases, higher stages, and the minor SG as the primary tumor site were identified as factors affecting the outcome of SDC.